Page results
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This booklet has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
File results
-
FOI/2024/0228 - Radiology Information Systems (RIS) software
-
FOI/2024/0230 - Physician Associate/ Anaesthesia Associate prescribing medication 2022/23-2023/24
-
FOI/2024/0232 - Freedom of Information requests and staffing 2020/21-2022/23
-
FOI/2024/0238 - Haematology and immunoglobulin treatments
-
FOI/2024/0243 - Pathology laboratory service/ information system at Trust
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0255 - Ingenica stock management system in theatres
-
FOI/2024/0259 - Clinical attachments for international medical graduates
-
FOI/2024/0263 - Longest wait for ophthalmology pathway treatment